Excelsior Medical Co., Ltd. (4104.TW)
- Previous Close
91.80 - Open
91.80 - Bid 91.50 x --
- Ask 91.60 x --
- Day's Range
91.20 - 92.80 - 52 Week Range
81.52 - 101.90 - Volume
262,914 - Avg. Volume
304,610 - Market Cap (intraday)
14.255B - Beta (5Y Monthly) 0.10
- PE Ratio (TTM)
19.16 - EPS (TTM)
4.78 - Earnings Date --
- Forward Dividend & Yield 3.80 (4.14%)
- Ex-Dividend Date Apr 19, 2024
- 1y Target Est
--
Excelsior Medical Co., Ltd. sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, the Philippines, and Malaysia. The company offers equipment for hemodialysis/plasma exchange; blood bag; artificial stoma; scar care products; and health appliances. It also maintains, leases, and sells medical equipment for beauty treatment; sells consumables of beauty treatment, as well as cosmetic products; retails and wholesales medical equipment, cosmetic health-care products, and medical herbs; sells and treats hair protecting and conditioning; sells aesthetic medical and cosmetic health-care products. In addition, the company offers medical management consultancy, and logistics services, as well as academic training. Further, it engages in the investment, real estate, and leasing businesses, as well as selling of precision instrument. The company was incorporated in 1988 and is based in New Taipei City, Taiwan.
www.excelsiormedical.com.twRelated News
Performance Overview: 4104.TW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4104.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4104.TW
Valuation Measures
Market Cap
14.29B
Enterprise Value
12.32B
Trailing P/E
19.21
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.74
Price/Book (mrq)
1.66
Enterprise Value/Revenue
1.50
Enterprise Value/EBITDA
8.64
Financial Highlights
Profitability and Income Statement
Profit Margin
9.07%
Return on Assets (ttm)
2.54%
Return on Equity (ttm)
8.70%
Revenue (ttm)
8.23B
Net Income Avi to Common (ttm)
746.6M
Diluted EPS (ttm)
4.78
Balance Sheet and Cash Flow
Total Cash (mrq)
3.41B
Total Debt/Equity (mrq)
13.22%
Levered Free Cash Flow (ttm)
-84.71M
Research Analysis: 4104.TW
Company Insights: 4104.TW
4104.TW does not have Company Insights